4-carboxy-5-[(4-chlorophenyl)-sulfanyl]-1,2,3-thiadiazole (CCPST) is a specific inhibitor of HAO1 and has been used for substrate reduction therapy in a mouse model of primary hyperoxaluria Type 1 [10]. Here, HAO1 is linked to primary hyperoxaluria type 1.